June 4, 2021 10:48 AM EDT
News Briefing

Fate sees pos­i­tive B-cell lym­phoma da­ta at #AS­CO21; Imag­inAb se­cures fund­ing for CD8 imag­ing tri­als

Max Gelman

Senior Editor

Josh Sullivan

Fate Ther­a­peu­tics re­vealed some new da­ta at #AS­CO21 for their R/R B-cell lym­phoma pro­gram on Fri­day.

The San Diego biotech

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Will CRISPR mat­ter?

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

Eli Lil­ly stock­piles $548M of oral weight loss drug ahead of launch

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times